GT Biopharma, Inc. (GTBP)
NASDAQ·Healthcare·Biotechnology
$0.28
+0.61%
Mkt Cap $4.54M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 2, 2026 | — | — | — | -$0.22 | -$2.22 | -909.09% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$0.38 | -$0.83 | -118.42% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.68 | -$0.55 | +19.12% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.64 | -$0.76 | -18.75% | — | — |
| Q1 2025 Feb 21, 2025 | — | — | — | -$1.55 | -$1.66 | -7.10% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$2.70 | -$1.53 | +43.33% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$2.70 | -$2.24 | +17.04% | — | — |
| Q2 2024 May 15, 2024 | — | — | — | -$2.70 | -$2.12 | +21.48% | — | — |
| Q2 2024 Apr 4, 2024 | — | — | — | -$2.70 | -$2.19 | +18.89% | — | — |
| Q4 2023 Nov 1, 2023 | — | — | — | -$3.00 | -$1.80 | +40.00% | — | — |
| Q3 2023 Aug 7, 2023 | — | — | — | -$3.00 | -$2.70 | +10.00% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$4.80 | -$2.40 | +50.00% | — | — |
| Q1 2023 Mar 30, 2023 | — | — | — | -$0.17 | -$5.41 | -3082.35% | — | — |
| Q4 2022 Oct 31, 2022 | — | — | — | -$3.30 | -$6.61 | -100.30% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$5.41 | -$3.00 | +44.55% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$6.91 | -$5.11 | +26.05% | — | — |
| Q1 2022 Mar 28, 2022 | — | — | — | -$6.31 | -$15.62 | -147.54% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$6.31 | -$5.11 | +19.02% | — | — |
| Q3 2021 Aug 23, 2021 | — | — | — | -$8.41 | -$4.50 | +46.49% | — | — |
| Q2 2021 May 17, 2021 | — | — | — | -$7.51 | -$54.95 | -631.69% | — | — |